APA (7th ed.) Citation

M, A., AW, A., NT, I., AS, P., R, v. E., T, F., & T, T. (2026). A Response to: "Letter to the Editor Regarding 'Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis'". Dermatology and therapy. https://doi.org/10.1007/s13555-026-01798-8

Chicago Style (17th ed.) Citation

M, Augustin, Armstrong AW, Issa NT, Petersen AS, von Eyben R, Festini T, and Torres T. "A Response to: "Letter to the Editor Regarding 'Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis'"." Dermatology and Therapy 2026. https://doi.org/10.1007/s13555-026-01798-8.

MLA (9th ed.) Citation

M, Augustin, et al. "A Response to: "Letter to the Editor Regarding 'Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis'"." Dermatology and Therapy, 2026, https://doi.org/10.1007/s13555-026-01798-8.